Results 81 to 90 of about 1,786 (140)

Recent Research on the Treatment of Vulvar and Vaginal Atrophy

Clinical and Experimental Obstetrics & Gynecology, 2022
Ottavia D'Oria, Andrea Giannini, Donatella Caserta   +2 more
doaj   +1 more source

Publication Only

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

VULVAR AND VAGINAL GRAFT VERSUS HOST DISEASE IN A PATIENT WITH CHRONIC PHASE CHRONIC MYELOID LEUKEMIA AFTER ALLOGENEIC STEM CELL TRANSPLANTATION

Hematology, Transfusion and Cell Therapy
Objective: Graft versus Host Disease (GVHD) is one of the serious complications of allogeneic stem cell transplantation used in the treatment of many hematological malignancies. Skin, liver, and eyes are frequently affected areas.
Esra Pirinççi, M. Orhan Ayyıldız, Abdullah Karakuş, Reyhan Gündüz   +3 more
doaj   +1 more source

The clinical role of LASER for vulvar and vaginal treatments in gynecology and female urology: An ICS/ISSVD best practice consensus document

, 2019
BACKGROUND The clinical role of LASER for vulvar and vaginal treatments in gynecology and female urology is controversial. AIMS In this best practice document, we propose recommendations for the use of LASER for gynecologic and urologic conditions such ...
TARCAN, TUFAN
core   +1 more source

The Safety of Local Hormonal Treatment for Vulvovaginal Atrophy in Women With Estrogen Receptor-positive Breast Cancer Who Are on Adjuvant Aromatase Inhibitor Therapy: Meta-analysis

, 2019
© 2019 Elsevier Inc. Atrophic vaginitis is a relatively common adverse effect of aromatase inhibitors used as an adjunctive treatment for breast cancer.
Milovanovic, Olivera, Mamillapali C., Folic, Marko, Stefanovic, Srdjan, Milovanovic, Jasmina, Milosavljević, Miloš, Jankovic, Slobodan, Pavlovic, Radisa   +7 more
core   +1 more source

Safety and efficacy of non-ablative CO2 laser treatment of vulvo-vaginal atrophy in women with history of breast cancer

Purpose Breast cancer survivors (BCS) suffer severe vulvo-vaginal atrophy (VVA) and some of the most effective therapies are contraindicated. In literature we have no data about the non-ablative CO2 laser on these women.
Seracchioli, Renato, Zanella, Sara, Meriggiola, Maria Cristina, Baldassarre, Maurizio, Amati, Veronica, Alvisi, Stefania, Lami, Alessandra   +6 more
core   +1 more source

Review of clinical studies on the use of agents based on sodium hyaluronate and phytoestrogens for the prevention and treatment of genitourinary syndrome of menopause [PDF]

РМЖ. Мать и дитя
Yu.E. Dobrokhotova1, I.A. Lapina1, E.A. Markova1, O.Yu. Katikova2 1Pirogov Russian National Research Medical University, Moscow, Russian Federation 2Biotechpharm LLC, Moscow, Russian Federation The perimenopausal transition represents a ...
Yu.E. Dobrokhotova, I.A. Lapina, E.A. Markova, O.Yu. Katikova   +3 more
doaj  

Non-hormonal therapy of atrophic vaginitis at different postmenopausal stages [PDF]

РМЖ. Мать и дитя
Yu.E. Dobrokhotova, A.Kh. Karanasheva Pirogov Russian National Research Medical University, Moscow, Russian Federation Aim: to evaluate efficacy of a non-hormonal agent containing phytoestrogens, lactobacilli, and hyaluronic acid in correcting ...
Yu.E. Dobrokhotova, A.Kh. Karanasheva
doaj  

Effectiveness of Combination of Tibolone and Lactobacilli Plus Lactoferrin in Postmenopausal Women with Vulvar Vestibular Pain: A Preliminary Report

Background: Postmenopausal dyspareunia and vulvar pain are common complaints, affecting about 60% of women within a few years after hormone levels begin to decline (such as estrogen and androgen).
Laura Governini, Vincenzo De Leo, Rosetta Ponchia, Dario Recalcati, Filippo Murina   +4 more
core   +1 more source

WISDOM survey: attitudes and behaviors of physicians toward vulvar and vaginal atrophy (VVA) treatment in women including those with breast cancer history. [PDF]

Menopause, 2019
Kingsberg SA, Larkin L, Krychman M, Parish SJ, Bernick B, Mirkin S.   +5 more
europepmc   +1 more source